N.E.W. Advisory Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

N.E.W. Advisory Services’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$55.1K	Buy	465 +1	+0.2%	+$108	﹤0.01%	359
2026 Q1	$48.2K	Buy	464 +1	+0.2%	+$106	﹤0.01%	376
2025 Q4	$48.4K	Buy	463 +6	+1%	+$604	﹤0.01%	358
2025 Q3	$42.2K	Buy	457 +1	+0.2%	+$88	﹤0.01%	340
2025 Q2	$36.4K	Sell	456 -412	-47%	-$32.9K	﹤0.01%	356
2025 Q1	$75.2K	Buy	+868	New	+$73.9K	0.01%	309

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

N.E.W. Advisory Services's PJP Position: Q2 2026 in Review

N.E.W. Advisory Services increased its Invesco Pharmaceuticals ETF (PJP) stake by 0.22% in Q2 2026, buying an estimated $108 and bringing the position to 465 shares worth $55.1K. The position accounts for ﹤0.01% of the portfolio, ranked #359.

N.E.W. Advisory Services first reported a position in PJP in Q1 2025 and has held it in 6 quarters since. The position peaked at $75.2K in Q1 2025. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

N.E.W. Advisory Services held 465 shares of Invesco Pharmaceuticals ETF worth $55.1K as of Q2 2026.
N.E.W. Advisory Services bought 1 Invesco Pharmaceuticals ETF share in Q2 2026, an estimated $108.
Invesco Pharmaceuticals ETF made up ﹤0.01% of N.E.W. Advisory Services's portfolio in Q2 2026, its #359 holding.
N.E.W. Advisory Services first reported a position in Invesco Pharmaceuticals ETF in Q1 2025 and has held it in 6 quarters since.
N.E.W. Advisory Services's Invesco Pharmaceuticals ETF position peaked at $75.2K in Q1 2025.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on N.E.W. Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.